Alberta Investment Management Corp (AIMCo)’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,378
Closed -$610K 1307
2022
Q2
$610K Buy
+3,378
New +$604K ﹤0.01% 1022
2020
Q4
Sell
-8,900
Closed -$1.46M 972
2020
Q3
$1.46M Sell
8,900
-1,000
-10% -$165K 0.02% 585
2020
Q2
$1.37M Buy
+9,900
New +$909K 0.02% 577
2019
Q3
Sell
-12,300
Closed -$1.58M 966
2019
Q2
$1.58M Buy
+12,300
New +$1.71M 0.01% 541
2018
Q2
Sell
-6,900
Closed -$645K 859
2018
Q1
$645K Buy
+6,900
New +$516K 0.01% 655
2016
Q3
Sell
-13,600
Closed -$452K 763
2016
Q2
$452K Buy
+13,600
New +$439K 0.01% 578

Other funds holding MED

Alberta Investment Management Corp (AIMCo)'s MED Position: Q3 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Medifast (MED) in Q3 2022, closing a stake of 3,378 shares — an estimated $610K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MED in Q2 2016 and held it in 6 quarters. The position peaked at $1.58M in Q2 2019. 264 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 3,378 Medifast shares in Q3 2022, an estimated $610K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Medifast in Q2 2016 and held it in 6 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Medifast position peaked at $1.58M in Q2 2019.
  • 264 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2022, filed 14 Nov 2022.